Annual Report and Accounts

RNS Number : 3926N

Immupharma PLC

10 June 2010

 



For Immediate Release

10 June 2010

ImmuPharma PLC

Annual Report and Accounts

Notice of Annual General Meeting : 17 June 2010

In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2009, has been posted to shareholders.

The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.

The Company's Annual General Meeting will be held on 17 June 2010 at 11am at 50 Broadway, London, SW1H 0BL.

-     Ends  -

For further information please contact:

ImmuPharma PLC:
Dimitri Dimitriou, Chief Executive Officer	[phone]
Richard Warr, Chairman	[phone]
Buchanan Communications	+ 44 20 7466 5000
Lisa Baderoon	www.buchanan.uk.com
Catherine Breen
George Prassas
Panmure Gordon & Co
Andrew Burnett	[phone]
Rakesh Sharma

 

END

 

 

ACSFMMLTMBABMIM